De bivirkninger, der er rapporteret af investigator, og som i hvert fald muligvis kan tilskrives
ra The adverse reactions reported by the investigator as at least possibly related to fondaparinux are presented within each frequency grouping (very common ≥ 1/ 10; common: ≥ 1/ 100 to < 1/ 10;